We are live on ! Find out more
KRON

Kronos Bio

Delisted

KRON was delisted on the 20th of June, 2025.

53 hedge funds and large institutions have $19.7M invested in Kronos Bio in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

1.68% less ownership

Funds ownership: 34.36%32.68% (-1.7%)

5% less funds holding

Funds holding: 5653 (-3)

23% less capital invested

Capital invested by funds: $25.6M → $19.7M (-$5.86M)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

41% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 17

Holders
53
Holders Change
-3
Holders Change %
-5.36%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
7
Increased
10
Reduced
17
Closed
10
Calls
$9K
Puts
Net Calls
+$9K
Net Calls Change
-$30K
Name Holding Trade Value Shares
Change
Change in
Stake
DCBT
51
Dakota Community Bank & Trust
North Dakota
$943
JP Morgan Chase
52
JP Morgan Chase
New York
$452 +$113 +102 +29%
Mariner
53
Mariner
Kansas
-$1.29M -1,041,031 Closed
AG
54
Artal Group
Luxembourg
-$1.05M -842,954 Closed
PFMU
55
Privium Fund Management (UK)
United Kingdom
-$342K -292,182 Closed
Jane Street
56
Jane Street
New York
-$96.3K -77,688 Closed
CIC
57
Cornercap Investment Counsel
Georgia
-$49.9K -40,208 Closed
CSS
58
Cubist Systematic Strategies
Connecticut
-$25K -20,174 Closed
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
-$2.59K -2,088 Closed
Simplex Trading
60
Simplex Trading
Illinois
-$2.08K -1,881 -93%
Citigroup
61
Citigroup
New York
-$898 -724 Closed
Qube Research & Technologies (QRT)
62
Qube Research & Technologies (QRT)
United Kingdom
-$368 -297 Closed

KRON Hedge Fund Activity: Q3 2024 in Review

53 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q3 2024, worth a combined $19.7M — down 23% from $25.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of KRON and 7 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 10 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $343K. The largest seller was Mariner, exiting entirely with an estimated $1.29M sold.

  • 53 institutional investors held Kronos Bio (KRON) as of Q3 2024, down from 56 in Q2 2024.
  • Funds reported $19.7M of Kronos Bio stock for Q3 2024, down 23% quarter-over-quarter.
  • 7 funds opened new Kronos Bio positions in Q3 2024 and 10 closed out, a net change of -3 holders.
  • The largest Kronos Bio buyer in Q3 2024 was Woodline Partners, an estimated $343K added.
  • The largest Kronos Bio seller in Q3 2024 was Mariner, an estimated $1.29M sold.

Based on aggregated 13F filings for Q3 2024.